Skip to main content
Qiagen N.V. logo

Qiagen N.V. — Investor Relations & Filings

Ticker · QIA ISIN · NL0015001WM6 LEI · 54930036WK3GMCN17Z57 F Manufacturing
Open in API
Filings indexed 627 across all filing types
Latest filing 2015-07-30 AGM Information
Country NL Netherlands
Listing F QIA

About Qiagen N.V.

https://www.qiagen.com/

Qiagen N.V. is a global provider of "Sample to Insight" solutions, offering technologies that transform biological materials into valuable molecular insights. The company develops and markets sample and assay technologies, automated instrumentation, and bioinformatics software for molecular diagnostics, applied testing, academic research, and pharmaceutical development. Its comprehensive portfolio supports the entire workflow from sample collection and preparation of DNA, RNA, and proteins to analysis and interpretation. Key product areas include sample preparation kits, PCR, digital PCR (dPCR), and next-generation sequencing (NGS) solutions, as well as syndromic testing panels for infectious diseases.

Recent filings

Filing Released Lang Actions
FORM 6-K
AGM Information Classification · 95% confidence The document is a Form 6-K filed by a foreign private issuer, QIAGEN N.V., with the SEC. It contains a detailed Notice of Annual General Meeting (AGM) of Shareholders, including the agenda, voting items, reappointments of board members, authorization items, and instructions for attendance and proxy voting. It also references the availability of the Annual Report 2014 and Annual Accounts for Fiscal Year 2014 but does not contain the full annual report or financial statements itself. The document is primarily focused on the AGM notice and related materials, not the report itself. Therefore, it fits the category of AGM Information (AGM-R). The document length is substantial (15,000 characters), indicating it is not a brief announcement but the full AGM notice and related proxy materials. Hence, the classification is AGM-R with high confidence.
2015-07-30 English
QIAGEN reports results for second quarter and first half of 2015
Earnings Release Classification · 98% confidence The document is titled "QIAGEN reports results for second quarter and first half of 2015" and contains detailed financial tables, key performance indicators (KPIs) like adjusted net sales, operating income, EPS for both Q2 and H1 2015, and management commentary on business performance and outlook. This structure is characteristic of a periodic financial results announcement. Since it covers a period shorter than a full year (Q2 and H1), it is not a 10-K (Annual Report). It is more detailed than a typical Earnings Release (ER) which usually provides only the highlights, but it is not a full Call Transcript (CT) or a comprehensive annual filing. Given the detailed financial breakdown for a half-year period, the most appropriate classification is Interim / Quarterly Report (IR). The document length is substantial (over 50,000 characters), confirming it is the report itself, not just an announcement of the report (RPA/RNS). Q2 2015
2015-07-30 English
6-K
Capital/Financing Update Classification · 95% confidence The document is a Form 6-K filed by QIAGEN N.V., which is a report of a foreign private issuer pursuant to the Securities Exchange Act of 1934. The content focuses on the announcement of the commencement of the third tranche of a previously announced share repurchase program. It includes details about the share buyback plan, regulatory compliance, and authorization by the Annual General Meeting. The document is not a full financial report but an update on capital activity related to share repurchases. Therefore, it fits the category of Capital/Financing Update (CAP). The document length is 5743 characters, which is sufficient to contain substantive information about the financing activity rather than just an announcement of a report publication or a brief notice.
2015-05-12 English
Interim / Quarterly Report 2015
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed with the SEC by QIAGEN N.V., a foreign private issuer. It explicitly contains a 'U.S. GAAP Quarterly Report for the Period Ended March 31, 2015' as an exhibit, which includes comprehensive condensed consolidated financial statements (balance sheets, income statements, cash flows) and management discussion. Per the filing definitions, a comprehensive financial report for a period shorter than a full fiscal year containing actual financial statements is classified as an Interim/Quarterly Report (IR). Q1 2015
2015-05-07 English
6-K
Interim / Quarterly Report Classification · 100% confidence The document is a Form 6-K filed by QIAGEN N.V. for the quarterly period ended March 31, 2015. It includes detailed unaudited condensed consolidated financial statements such as balance sheets, income statements, statements of comprehensive income, changes in equity, and cash flows, along with notes and management discussion sections. The presence of comprehensive financial data for a quarterly period and the explicit mention of a quarterly report prepared under U.S. GAAP indicates this is an Interim / Quarterly Report. Form 6-K is used by foreign private issuers to furnish reports that are similar to quarterly reports (10-Q) filed by U.S. companies. Therefore, the appropriate classification is Interim / Quarterly Report (IR). The document length (15,000 characters) and detailed financial content confirm it is the report itself, not just an announcement or certification.
2015-05-06 English
6-K
Interim / Quarterly Report Classification · 95% confidence The document is a Form 6-K filed by QIAGEN N.V. for the quarterly period ended March 31, 2015. It includes detailed unaudited financial results for Q1 2015, including adjusted net sales, operating income, net income, EPS, and free cash flow. The document discusses financial performance, business review, and management commentary on results and outlook. The presence of detailed financial data and analysis for a quarterly period indicates this is an Interim / Quarterly Report. The document is not a full Annual Report (10-K), nor is it a short announcement or press release only. It is not a certification or attestation, so it is not Regulatory Filings (RNS). The document length and content confirm it is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim / Quarterly Report (IR).
2015-05-06 English

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.